Only 1 shot of two-dose vaccine may require for Covid survivors
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
MONDAY, MAY 23, 2022
MONDAY, MAY 23, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Only 1 shot of two-dose vaccine may require for Covid survivors

Coronavirus chronicle

TBS Report
18 April, 2021, 10:30 am
Last modified: 18 April, 2021, 12:39 pm

Related News

  • Covax calls for urgent action to close vaccine equity gap
  • China Junshi's potential Covid drug shows promise in small trial
  • Indonesia to drop outdoor mask mandate as Covid-19 infections drop
  • N Korean leader slams officials' 'immaturity' in response to Covid outbreak
  • Shanghai achieves 'zero Covid' status but normal life is weeks away

Only 1 shot of two-dose vaccine may require for Covid survivors

The issue of giving only a single dose to people who have had Covid has become all the more urgent since safety concerns have been raised about Johnson & Johnson’s and AstraZeneca’s vaccines

TBS Report
18 April, 2021, 10:30 am
Last modified: 18 April, 2021, 12:39 pm
Photo: Bloomberg
Photo: Bloomberg

If one had suffered from Covid, he/she may only need one of the two doses recommended by Pfizer and Moderna, according to a research.

Conducted on the staffers of Cedars-Sinai Medical Center in Los Angeles, the study has shown a clear pattern that those who had recovered from Covid-19, responded to the first shot robustly than those never-infected ones who received both shots, reports Bloomberg.

"We did not expect that this was going to jump out like a smoking gun," said research leader Susan Cheng, who co-authored the Nature Medicine write-up. In fact, if you already had the virus, your immune response after one vaccine is likely to be even better than a never-infected person's after two, according to Italian research just out in the New England Journal of Medicine.

The issue of giving only a single dose to people who have had Covid has become all the more urgent since safety concerns have been raised about Johnson & Johnson's and AstraZeneca's vaccines. The implications at a time of strained global supply are striking: giving previously infected people just one mRNA vaccine shot could free up more than 110 million doses worldwide, according to a calculation by University of Maryland School of Medicine immunologist Mohammad Sajadi and colleagues.

'Remembering' covid

Sajadi co-authored one of the recent studies that fit into a recent flurry of findings all pointing in the same direction: The immune system in people who've had Covid "remembers" the virus, so a first vaccine acts as a powerful booster for existing defenses. "The data is very clear," Sajadi said. "Every study has shown you get a very clear and strong memory response."

Since February, several European countries -- including France, Spain, Italy and Germany -- have adopted policies giving Covid survivors just one dose of the two-dose vaccines.

In Israel, a world leader on coronavirus vaccinations, health authorities initially withheld vaccines altogether from recovered Covid patients, but in February recommended they receive one shot. New research there suggests that the booster vaccine adds protection against newer variants that originated in the UK, South Africa and Brazil.

"We think that our study supports the recommendation to administer one vaccine dose to recovered individuals to protect against the original and SARS-CoV-2 variants of concern," Michal Mandelboim, head of Israel's National Center for Influenza and Respiratory Viruses, said in an email. A study in "Science" found that in Covid survivors, vaccinations massively boosted immunity against variants.

In the US, the Centers for Disease Control and Prevention still recommends two vaccine doses for people who have had Covid, but the mounting evidence that one vaccine could be enough is under discussion. The US has administered enough doses for 31% of its population, while Israel has given enough for 57%, according to the Bloomberg Vaccine Tracker.

Data Needed

In a blog post, National Institutes of Health Director Francis Collins raised the possibility that giving survivors a single dose could "help to extend vaccine supply and get more people vaccinated sooner."

"But any serious consideration of this option will require more data," he cautioned in February.

Since then, one study after another has reinforced the single-vaccine-for-survivors idea, though some skeptics have pointed out that it is logistically simpler to just give everyone two doses than to figure out who needs only one.

In the US, vaccine supplies are relatively copious, Sajadi said. But "for other countries, especially places that are having a hard time getting vaccine, this is really still an important question. And it's also an important question in general because you don't want to just give someone a medical intervention they don't need."

If a patient who'd had Covid asked Sajadi at this point whether they needed a second vaccine, he said, he'd say it would make sense to skip it if nothing in their medical history indicated issues with immune responses.

Cheng at Cedars-Sinai said she would still default to the CDC guidance calling for two vaccines, even for people who've had Covid. The data does suggest, however, that one dose could be enough, she said -- and that could be true for other types of people as well: "I think we're just at the tip of the iceberg of figuring out who they are."

Top News / World+Biz

Vaccine / Covid

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • BPC hunts for dollar to import fuel oil
    BPC hunts for dollar to import fuel oil
  • Representational Image. Photo: Mumit M/TBS
    Govt to list products to suspend imports amid dollar crisis
  • Infographic: TBS
    With 2 months left, 45% ADP fund still unspent 

MOST VIEWED

  • A person in personal protective equipment (PPE) walks a dog at a resident community, as the second stage of a two-stage lockdown has been launched to curb the spread of the coronavirus disease (Covid-19) in Shanghai, China April 3, 2022. REUTERS/Aly Song
    Shanghai reopens some public transport, still on high Covid alert
  • Workers in protective suit spray disinfectant at a community, during the lockdown to curb the spread of the coronavirus disease (COVID-19) in Shanghai, China, April 5, 2022. REUTERS/Aly Song
    Dynamic zero-Covid approach: China's choice to safeguard lives, underpin growth
  • People wearing protective face masks walk on a street, following new cases of the coronavirus disease (Covid-19), in Shanghai, China August 25, 2021. REUTERS/Aly Song
    Shanghai district to require all shops to shut, residents to stay home
  • Photo: Courtesy
    Covax calls for urgent action to close vaccine equity gap
  • Photo: BSS/AFP
    Covax calls for urgent action to close vaccine equity gap
  • Photo: Collected
    Thousands of Covid-negative Beijing residents sent to quarantine

Related News

  • Covax calls for urgent action to close vaccine equity gap
  • China Junshi's potential Covid drug shows promise in small trial
  • Indonesia to drop outdoor mask mandate as Covid-19 infections drop
  • N Korean leader slams officials' 'immaturity' in response to Covid outbreak
  • Shanghai achieves 'zero Covid' status but normal life is weeks away

Features

Why everybody wants to be like TikTok

Why everybody wants to be like TikTok

14h | Panorama
Illustration: TBS

How the ban on porn sites spawned a local cybersex industry

16h | Panorama
3 best affordable sunscreens for all

3 best affordable sunscreens for all

17h | Mode
Warah uses three types of khadi material: a sheer and light one, a medium count and a thicker one.

Warah: Embroidered with culture and womanhood

19h | Mode

More Videos from TBS

Investors, public to suffer from electricity price hike

Investors, public to suffer from electricity price hike

6h | Videos
Health benefits of summer fruits

Health benefits of summer fruits

7h | Videos
The way Bangladesh saves almost extinct fish

The way Bangladesh saves almost extinct fish

7h | Videos
Padma’s Char now largest grazing-ground

Padma’s Char now largest grazing-ground

8h | Videos

Most Read

1
Tk100 for bike, Tk2,400 for bus to cross Padma Bridge
Bangladesh

Tk100 for bike, Tk2,400 for bus to cross Padma Bridge

2
A packet of US five-dollar bills is inspected at the Bureau of Engraving and Printing in Washington March 26, 2015. REUTERS/Gary Cameron
Banking

Dollar hits Tk100 mark in open market

3
PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire
Crime

PK Halder: How a scamster rose from humble beginnings to a Tk11,000cr empire

4
Bangladesh at risk of losing ownership of Banglar Samriddhi
Bangladesh

Bangladesh at risk of losing ownership of Banglar Samriddhi

5
BSEC launches probe against Abul Khayer Hero and allies
Stocks

BSEC launches probe against Abul Khayer Hero and allies

6
The story of Bangladesh becoming a major bicycle exporter
Industry

The story of Bangladesh becoming a major bicycle exporter

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab